KCG
IMMU

Knight Capital Group’s Immunomedics Inc IMMU Stock Holding History

Knight Capital Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$65K Buy
+11,995
New +$39.4K ﹤0.01% 3026

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Knight Capital Group's IMMU Position: Q2 2013 in Review

Knight Capital Group opened a new position in Immunomedics Inc (IMMU) in Q2 2013: 11,995 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #3026 among its holdings.

79 funds tracked by Wall St. Rank hold IMMU as of Q2 2013.

  • Knight Capital Group held 11,995 shares of Immunomedics Inc worth $65K as of Q2 2013.
  • Immunomedics Inc was a new Knight Capital Group position in Q2 2013.
  • Immunomedics Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3026 holding.
  • 79 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.